Biogen BIIB
NASDAQ BIIB
$250.69 -3.15 (-1.24%)
At close: Oct 23, 2026 · 4:00 PM EDT

Biogen (BIIB) Cost of Revenue (2009 - 2026)

Updated

Biogen (BIIB) recorded Cost of Revenue of $776.9 million in Q2 2026, up 28.4% from $605 million a year earlier and up 17.5% from the prior quarter.

Analysis

Biogen (BIIB) Cost of Revenue (2009 - 2026) Analysis & Trends

On a TTM basis, Biogen's Cost of Revenue came in at $2.61 billion as of Jun 30, 2026, up 6.2% year-over-year; for FY2025, it was $2.4 billion, up 4.1% from FY2024.

  • Annual Cost of Revenue has a five-year compound annual growth rate of 5.9% (FY2020 to FY2025).
  • Across earlier years, Cost of Revenue came in at $2.31 billion in FY2024 (-8.8%), $2.53 billion in FY2023 (+11.2%), $2.28 billion in FY2022 (+8.0%) and $2.11 billion in FY2021 (+16.9%).
  • The Q2 2026 figure is the highest quarterly Cost of Revenue in data going back to Q1 2009.
  • On a year-over-year basis, Cost of Revenue rose in five of the last eight quarters, with growth averaging 5.3%.
  • Peak year-over-year performance for Cost of Revenue in the last five years was growth of 57.7% in Q1 2022, against a decline of 18.2% in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $661 million (Q1 2026), $495.5 million (Q4 2025) and $674.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Biogen 37.04 Bn 23.70 Bn 1.96 Bn 776.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 776.90 Mn
Mar 31, 2026 661.00 Mn
Dec 31, 2025 495.50 Mn
Sep 30, 2025 674.40 Mn
Jun 30, 2025 605.00 Mn
Mar 31, 2025 629.30 Mn
Dec 31, 2024 583.50 Mn
Sep 30, 2024 638.70 Mn
Jun 30, 2024 546.00 Mn
Mar 31, 2024 542.20 Mn
Dec 31, 2023 618.30 Mn
Sep 30, 2023 659.60 Mn
Jun 30, 2023 592.70 Mn
Mar 31, 2023 662.80 Mn
Dec 31, 2022 570.90 Mn
Sep 30, 2022 469.50 Mn
Jun 30, 2022 484.00 Mn
Mar 31, 2022 753.90 Mn
Dec 31, 2021 660.10 Mn
Sep 30, 2021 511.80 Mn
API Access

Biogen Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BIIB&period=max&api_key=YOUR_API_KEY